Search Results - Mathieu Uzzan

Letter: Toward Intra‐Class Switching With JAK Inhibitors? by Mathieu Uzzan, David Laharie

Get full text

CAR‐T Cells in Ulcerative Colitis: The Renaissance of B‐Cell Targeted Therapy in UC by Zlata Chkolnaia, Mathieu Uzzan, Walter Reinisch

Get full text

Editorial: JAK to JAK—Navigating Intra‐Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply by Mathieu Uzzan, David Laharie, Julien Kirchgesner

Get full text

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study by Nathan Grellier, Julien Kirchgesner, Mathieu Uzzan, Paul Mclellan, Carmen Stefanescu, Jérémie H. Lefèvre, Xavier Treton, Yves Panis, Harry Sokol, Laurent Beaugerie, Philippe Seksik

Get full text

TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease by Zlata Chkolnaia, Benedicte Lebrun‐Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard, Maeva Charkaoui, Guillaume Le Cosquer, Carmen Stefanescu, Melanie Serrero, Laurianne Plastaras, Sophie Vieujean, David Laharie, Philippe Seksik

Get full text

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study by Nicolas Richard, Philippe Seksik, Romain Altwegg, Maria Nachury, David Laharie, Stéphane Nancey, Benoît Coffin, Anne‐Laure Pelletier, Mathieu Uzzan, Aurélien Amiot, Morgane Amil, Lucine Vuitton, Mathurin Fumery, Anne Bozon

Get full text

Building a Robust Investigator‐Initiated Platform: The I‐ CARE Experience by Julien Kirchgesner, Laurent Beaugerie, Cédric Baumann, Filip Baert, Jean‐François Rahier, Daniel Bergemalm, Fiorella Cañete, Bénédicte Caron, Marta Cossignani, Sandra Dias, Klaudia Farkas, Parker Girod, Idan Goren, Tom Holvoet, Susanne Krasz, Aditi Kumar, Peter Rimmer, Juliette Sheridan, Jessica Thut, Mathieu Uzzan, Nikos Viazis, Petra Weimers, Edyta Zagórowicz, Anne Buisson, Luisa Avedano, Helene Rousseau, Laurent Peyrin‐Biroulet, Shaji Sebastian

Get full text

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study by Mathilde Osty, Romain Altwegg, Mélanie Serrero, Alban Benezech, Albane Lecomte, Guillaume Cadiot, Lucine Vuitton, Anne Wampach, Stéphane Nancey, Anthony Buisson, Catherine le Berre, Clea Rouillon, Cyrielle Gilletta, Felix Goutorbe, Mathurin Fumery, Nassim Hammoudi, Ludovic Caillo, Mathias Vidon, Nadia Arab, Gaelle Sickersen, Maryan Cavicchi, Sophie Vieujean, Maeva Charkaoui, Nicolas Richard, Pauline Wils, Bénédicte Caron, Aurélien Amiot, Alexandre Nuzzo, David Laharie, Julien Kirchgesner, Mathieu Uzzan

Get full text

Efficacy and Safety of Second‐Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID by Louis Calméjane, Catherine Reenaers, Claire Gay, Aurélien Amiot, Alexandre Nuzzo, Lucine Vuitton, Calina Atanasiu, Carmen Stefanescu, Romain Altwegg, Lucas Guillo, Mélanie Serrero, Guillaume Bouguen, Maria Nachury, Guillaume Le Cosquer, Xavier Roblin, Vered Abitbol, Nassim Hammoudi, Marion Simon, Mathurin Fumery, Guillaume Savoye, Alban Benezech, Maryan Cavicchi, Maeva Charkaoui, Anthony Buisson, Bénédicte Caron, Benoît Coffin, Sophie Geyl, Félix Goutorbe, Marianne Hupé, Mathias Vidon, David Laharie, Julien Kirchgesner, Mathieu Uzzan

Get full text